The global market for GLP-1 receptor agonists is witnessing a surge in demand due to their proven results in managing type 2 diabetes. Several leading companies have earned FDA approval to produce these life-changing medications. {Novo Nordisk|Eli Lillyremains a leading producer of GLP-1 receptor agonists, with proven products like Wegovy. {S